ESGU vs VHT
iShares MSCI USA ESG Optimized ETF vs Vanguard Health Care ETF
- • VHT has the lower expense ratio at 0.09% vs 0.15% for ESGU.
- • VHT pays a higher dividend yield (1.35%).
Side-by-side metrics
| Metric | ESGU | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.94% | 1.35% |
AUM Assets under management — bigger funds are typically more liquid. | $17.82B | $23.73B |
YTD return | 11.27% | 22.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 0.46 |
P/E ratio | 24.29 | 32.41 |
Last price | $166.66 | $347.68 |
Inception | — | — |
Issuer | iShares | Vanguard |
ESGU top holdings
| AAPL | Apple Inc | 7.66% |
| NVDA | NVIDIA Corp | 7.25% |
| MSFT | Microsoft Corp | 5.71% |
| AMZN | Amazon.com Inc | 3.49% |
| GOOG | Alphabet Inc Class C | 2.89% |
| AVGO | Broadcom Inc | 2.29% |
| META | Meta Platforms Inc Class A | 1.91% |
| TSLA | Tesla Inc | 1.73% |
| LLY | Eli Lilly and Co | 1.70% |
| GOOGL | Alphabet Inc Class A | 1.59% |
VHT top holdings
| LLY | Eli Lilly and Co | 12.93% |
| JNJ | Johnson & Johnson | 8.78% |
| ABBV | AbbVie Inc | 6.45% |
| MRK | Merck & Co Inc | 5.01% |
| UNH | UnitedHealth Group Inc | 4.65% |
| TMO | Thermo Fisher Scientific Inc | 3.50% |
| AMGN | Amgen Inc | 3.18% |
| GILD | Gilead Sciences Inc | 2.58% |
| ABT | Abbott Laboratories | 2.40% |
| PFE | Pfizer Inc | 2.27% |
About ESGU
ESGU (iShares MSCI USA ESG Optimized ETF) is US large/mid-cap stocks with favorable ESG ratings. Managed by iShares, the fund carries $17.8B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.94%. Its largest holding is Apple Inc (AAPL), which represents 7.7% of the portfolio. Real Estate is the fund's largest sector exposure at 2.1%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.